Cell-mediated targeting drugs delivery systems

被引:103
|
作者
Yu, Hongli [1 ]
Yang, Zhihong [1 ]
Li, Fei [2 ]
Xu, Lisa [3 ]
Sun, Yong [1 ]
机构
[1] Qingdao Univ, Sch Pharm, Dept Pharmacol, Qingdao, Peoples R China
[2] Qingdao Univ, Affiliated Hosp, Dept Pharm, Qingdao, Peoples R China
[3] Qingdao Univ, Sch Publ Hlth, Qingdao, Peoples R China
基金
中国国家自然科学基金;
关键词
Cell-carriers; targeted drug delivery; immune cells; circulating cells; stem cells; targeting; RED-BLOOD-CELLS; THERAPEUTIC NANOPARTICLES; CANCER-TREATMENT; TROJAN HORSE; STEM-CELLS; IN-VIVO; CARRIERS; LEUKOCYTES; IMMUNOMODULATORS; FUNDAMENTALS;
D O I
10.1080/10717544.2020.1831103
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Drug delivery systems have shown tremendous promise to improve the diagnostic and therapeutic effects of drugs due to their special property. Targeting tissue damage, tumors, or drugs with limited toxicity at the site of infection is the goal of successful pharmaceuticals. Targeted drug delivery has become significantly important in enhancing the pharmaceutical effects of drugs and reducing their side effects of therapeutics in the treatment of various disease conditions. Unfortunately, clinical translation of these targeted drug delivery system mechanisms faces many challenges. At present, only a few targeted drug delivery systems can achieve high targeting efficiency after intravenous injection, even though numerous surface markers and targeting approaches have been developed. Thus, cell-mediated drug-delivery targeting systems have received considerable attention for their enhanced therapeutic specificity and efficacy in the treatment of the disease. This review highlights the recent advances in the design of the different types of cells that have been explored for cell-mediated drug delivery and targeting mechanisms. A better understanding of cell biology orientation and a new generation of delivery strategies that utilize these endogenous approaches are expected to provide better solutions for specific site delivery and further facilitate clinical translation.
引用
收藏
页码:1425 / 1437
页数:13
相关论文
共 50 条
  • [41] Targeting strategies for delivery of anti-HIV drugs
    Ramana, Lakshmi Narashimhan
    Anand, Appakkudal R.
    Sethuraman, Swaminathan
    Krishnan, Uma Maheswari
    JOURNAL OF CONTROLLED RELEASE, 2014, 192 : 271 - 283
  • [42] TGF-α Equalizes Age Disparities in Stem Cell-Mediated Cardioprotection
    Herrmann, Jeremy L.
    Fiege, Jeremy W.
    Abarbanell, Aaron M.
    Weil, Brent R.
    Wang, Yue
    Poynter, Jeffrey A.
    Manukyan, Mariuxi C.
    Brewster, Benjamin D.
    Meldrum, Daniel R.
    JOURNAL OF SURGICAL RESEARCH, 2012, 176 (02) : 386 - 394
  • [43] Dendritic Cell-Mediated In Vivo Bone Resorption
    Maitra, Radhashree
    Follenzi, Antonia
    Yaghoobian, Arash
    Montagna, Cristina
    Merlin, Simone
    Cannizzo, Elvira S.
    Hardin, John A.
    Cobelli, Neil
    Stanley, E. Richard
    Santambrogio, Laura
    JOURNAL OF IMMUNOLOGY, 2010, 185 (03) : 1485 - 1491
  • [44] Immune cell-mediated venous thrombus resolution
    Henke, Peter K.
    Nicklas, John M.
    Obi, Andrea
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2023, 7 (08)
  • [45] Cell-mediated effector molecules and complicated malaria
    Nyangoto, EO
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2005, 137 (04) : 326 - 342
  • [46] Local delivery systems of drugs/biologicals for the management of burn wounds
    Pal, Debajyoti
    Rath, Pritish
    Das, Pratik
    Kundu, Biswanath
    Nandi, Samit Kumar
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2023, 85
  • [47] The ATTEMPTS delivery systems for macromolecular drugs
    Kwon, Young Min
    Li, Yongtao
    Naik, Sarita
    Liang, Jun Feng
    Huang, Yongzhuo
    Park, Yoon Jeong
    Yang, Victor C.
    EXPERT OPINION ON DRUG DELIVERY, 2008, 5 (11) : 1255 - 1266
  • [48] Targeting delivery in Parkinson's disease
    Newland, Ben
    Dunnett, Stephen B.
    Dowd, Eilis
    DRUG DISCOVERY TODAY, 2016, 21 (08) : 1313 - 1320
  • [49] NK cell-mediated killing of target cells triggers robust antigen-specific T cell-mediated and humoral responses
    Krebs, Philippe
    Barnes, Michael J.
    Lampe, Kristin
    Whitley, Karen
    Bahjat, Keith S.
    Beutler, Bruce
    Janssen, Edith
    Hoebe, Kasper
    BLOOD, 2009, 113 (26) : 6593 - 6602
  • [50] A reproducible immunopotency assay to measure mesenchymal stromal cell-mediated T-cell suppression
    Bloom, Debra D.
    Centanni, John M.
    Bhatia, Neehar
    Emler, Carol A.
    Drier, Diana
    Leverson, Glen E.
    Mckenna, David H., Jr.
    Gee, Adrian P.
    Lindblad, Robert
    Hei, Derek J.
    Hematti, Peiman
    CYTOTHERAPY, 2015, 17 (02) : 140 - 151